The pharmacogenomics of selective serotonin reuptake inhibitors.
about
Citalopram and escitalopram plasma drug and metabolite concentrations: genome-wide associations.Effects of the serotonin type 2A, 3A and 3B receptor and the serotonin transporter genes on paroxetine and fluvoxamine efficacy and adverse drug reactions in depressed Japanese patients.Glycine and a glycine dehydrogenase (GLDC) SNP as citalopram/escitalopram response biomarkers in depression: pharmacometabolomics-informed pharmacogenomics.Transgenic elimination of high-affinity antidepressant and cocaine sensitivity in the presynaptic serotonin transporter.Catechol O-methyltransferase pharmacogenomics and selective serotonin reuptake inhibitor response.Genetics of suicide.Association study of a brain-derived neurotrophic-factor polymorphism and short-term antidepressant response in major depressive disorders.Mice genetically depleted of brain serotonin do not display a depression-like behavioral phenotype.A case study of the utility of the HapMap database for pharmacogenomic haplotype analysis in the Taiwanese population.Routine pharmacogenetic testing in clinical practice: dream or reality?Review of evidence for genetic testing for CYP450 polymorphisms in management of patients with nonpsychotic depression with selective serotonin reuptake inhibitors.SLC6A4 variation and citalopram response.Pharmacogenomics with antidepressants in the STAR*D study.Serotonin Transporter Polymorphism (5-HTTLPR) and Citalopram Effectiveness in Iranian Patients with Major Depressive Disorder.Epistasis between IL1A, IL1B, TNF, HTR2A, 5-HTTLPR and TPH2 variations does not impact alcohol dependence disorder features.Pharmacogenetics of selective serotonin reuptake inhibitors and associated adverse drug reactions.Pharmacogenomics of selective serotonin reuptake inhibitor treatment for major depressive disorder: genome-wide associations and functional genomicsSelective serotonin reuptake inhibitors pathwayAssociation study between vesicle-associated membrane protein 2 gene polymorphisms and fluvoxamine response in Japanese major depressive patients.Polymorphic Variations in 5-HT2A, 5-HTT and DISC 1 in First Episode Schizophrenia PatientsTemperament and character in mood disorders: influence of DRD4, SERTPR, TPH and MAO-A polymorphisms.Pharmacogenetics of citalopram-related side effects in children with depression and/or anxiety disorders.Pharmacogenomic evaluation of the antidepressant citalopram in the mouse tail suspension test.
P2860
Q34065310-E5266BE0-E09A-407F-8638-A2A0635C38D6Q34552006-A7AC5B8A-A6F5-465F-BCED-865A60D3F63CQ34555598-A148C3C6-FF35-4A4C-876F-DEE68994D78AQ34621173-536A8A5E-1694-49AE-B969-3D1F1FC35665Q35040545-55FBDA43-737D-452F-8B3B-95738F720A04Q36389314-3F8B25B8-BC86-43AE-9C3C-729B2BF642A2Q36441426-997D8D36-13A6-4AE6-B080-07155B4ED26FQ36648936-3A61B791-C132-4A8B-A743-713321A9C52AQ36677271-2C45FB05-4298-4D61-838F-67E43F3F0847Q36989859-032F1BD4-CC3A-45EC-9AAC-9EF2D9B7ACCBQ37037060-0D3E1DB7-9481-4C11-AB7F-15A69D3F42DBQ37139300-86A4FF12-B048-4DE7-BE4F-9F17C3698D60Q37205961-714B5ABE-9182-4B19-958B-2BCFB20B9B13Q37229060-602CADE9-2AE1-4B6C-8095-AB99633A6328Q37335368-166160DD-CB0A-42DD-BD58-1E89783971C7Q37532496-FC0CE286-2FF3-499D-A04A-EB5FF54F664BQ37614819-0AC29F50-C739-48F8-A617-176EDB4A6ED2Q42017738-6F9AA15C-D8B8-4C30-8DA8-3E9E4010213DQ42170893-F612A797-3F8B-4CCC-9BFE-EC04E583ED65Q42378554-B5706226-4AA7-4E7E-80A3-44FC9B22CDBCQ46828984-0E43DA79-7FCA-4FB1-946C-9C260F78E118Q47998122-F37C8F28-FF66-4BE7-952B-214CB550E02FQ52840990-D393C526-5E49-4DF9-824F-45FC49CA1E9C
P2860
The pharmacogenomics of selective serotonin reuptake inhibitors.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
The pharmacogenomics of selective serotonin reuptake inhibitors.
@ast
The pharmacogenomics of selective serotonin reuptake inhibitors.
@en
type
label
The pharmacogenomics of selective serotonin reuptake inhibitors.
@ast
The pharmacogenomics of selective serotonin reuptake inhibitors.
@en
prefLabel
The pharmacogenomics of selective serotonin reuptake inhibitors.
@ast
The pharmacogenomics of selective serotonin reuptake inhibitors.
@en
P2860
P356
P1476
The pharmacogenomics of selective serotonin reuptake inhibitors
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.TPJ.6500250
P577
2004-01-01T00:00:00Z